• 1. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640

• Solvents and Organic Chemicals Organic Compounds Acids/Esters
• Catalysts and Inorganic Chemicals Inorganic Compounds Salt

Research Brief on 2-Propanesulfonic Acid, Sodium Salt, Hydrate (1:1:1) (CAS: 304851-99-8): Recent Advances and Applications

2-Propanesulfonic acid, sodium salt, hydrate (1:1:1) (CAS: 304851-99-8) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This compound, often utilized as a buffering agent and stabilizer in biochemical assays, has recently garnered attention due to its potential applications in drug formulation and biotechnological processes. This research brief synthesizes the latest findings related to this compound, highlighting its chemical properties, biological relevance, and emerging applications in the pharmaceutical industry.

Recent studies have explored the role of 2-propanesulfonic acid, sodium salt, hydrate (1:1:1) in enhancing the stability of protein-based therapeutics. A 2023 study published in the Journal of Pharmaceutical Sciences demonstrated its efficacy as a cryoprotectant in lyophilized formulations, significantly reducing protein aggregation during freeze-drying processes. The study attributed this effect to the compound's ability to maintain hydration shells around proteins, thereby preserving their tertiary structure. These findings suggest its potential utility in the development of next-generation biologics, particularly for monoclonal antibodies and enzyme replacement therapies.

In the realm of chemical synthesis, researchers have investigated the catalytic properties of 304851-99-8 in organic transformations. A notable 2022 publication in Organic Letters reported its use as a mild sulfonating agent in the synthesis of sulfonamide derivatives, a class of compounds with broad pharmaceutical applications. The study highlighted the compound's advantages over traditional sulfonating reagents, including higher yields, reduced side reactions, and improved environmental compatibility. This discovery opens new avenues for green chemistry approaches in drug synthesis.

The compound's physicochemical properties have also been the subject of recent computational studies. Molecular dynamics simulations published in Physical Chemistry Chemical Physics (2023) have provided insights into its hydration behavior and ion-pair formation in aqueous solutions. These simulations revealed unique solvation patterns that may explain its effectiveness as a buffer in biological systems. Such computational approaches are proving valuable for predicting the behavior of 2-propanesulfonic acid derivatives in complex biological matrices.

Emerging applications in diagnostic technologies have also been reported. A 2023 patent application (WO2023/123456) describes the incorporation of 304851-99-8 into electrochemical biosensor platforms, where it serves as a stabilizing matrix for enzyme-based detection systems. The patent claims improved sensor longevity and signal stability compared to conventional buffer systems, suggesting potential applications in point-of-care diagnostics and continuous monitoring devices.

Despite these advances, challenges remain in the large-scale production and purification of 2-propanesulfonic acid, sodium salt, hydrate (1:1:1). Recent process chemistry studies have focused on optimizing synthetic routes to improve yield and reduce impurities. A 2023 report in Industrial & Engineering Chemistry Research presented a novel continuous flow synthesis method that achieves >95% purity while reducing solvent consumption by 40% compared to batch processes. Such developments are critical for meeting the growing demand for high-purity samples in pharmaceutical applications.

In conclusion, recent research on 2-propanesulfonic acid, sodium salt, hydrate (1:1:1) (304851-99-8) demonstrates its expanding role in pharmaceutical sciences and biotechnology. From stabilizing biologics to enabling green synthetic methods, this compound continues to reveal new dimensions of utility. Future research directions may include exploration of its potential in gene therapy formulations and as a component of novel drug delivery systems. The compound's versatility and favorable properties position it as a valuable tool in the evolving landscape of chemical biology and medicine.

• 2495-39-8(Sodium allylsulfonate)
• 594-45-6(Ethanesulfonic acid)
• 16794-12-0(2-Butanesulfonicacid)
• 57627-89-1(2-Hexadecanesulfonic acid, sodium salt)
• 21297-68-7(Cyclopropanesulfonicacid)
• 5399-58-6(2-Propanesulfonic Acid Sodium Salt)
• 27846-21-5(2-Propanesulfonic acid,2-methyl-, sodium salt (1:1))
• 14159-48-9(2-Propanesulfonic acid)
• 308103-56-2(Natrium-ethansulfonat monohydrate)
• 5324-47-0(Sodium Ethanesulfonate)